Clinical Trial Update: Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dexamethasone irrigation of parotid glands in Sjögren's syndrome with xerostomia; study terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome
• Xerostomia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Sjögren's Syndrome, Xerostomia | Phase 2 | Status: TERMINATED | Results posted: 2018-11-02